Standard Biotools (LAB) Long-Term Deferred Tax (2024 - 2026)

Standard Biotools (LAB) has 3 years of Long-Term Deferred Tax data on file, last reported at $270000.0 in Q1 2026.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $270000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270000.0 (changed N/A YoY) and the FY2025 annual result came in at $38.6 million, up 27891.3% from the prior year.
• Long-Term Deferred Tax declined to $270000.0 in Q1 2026 per LAB's latest filing, from $38.6 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $38.6 million in Q4 2025 and bottomed at $138000.0 in Q4 2024.
• The 3-year median for Long-Term Deferred Tax is $270000.0 (2026), against an average of $13.0 million.
• Peak annual rise in Long-Term Deferred Tax reached 27891.3% in 2025, while the deepest fall reached 27891.3% in 2025.
• Tracing LAB's Long-Term Deferred Tax over 3 years: stood at $138000.0 in 2024, then surged by 27891.3% to $38.6 million in 2025, then tumbled by 99.3% to $270000.0 in 2026.
• Per Business Quant, the three latest LAB Long-Term Deferred Tax figures stand at $270000.0 (Q1 2026), $38.6 million (Q4 2025), and $138000.0 (Q4 2024).

Peer Comparison